**Exhibit 31.1**

**CERTIFICATION****OF****CHIEF EXECUTIVE OFFICER**

**PURSUANT TO SECTION 302**

**OF THE SARBANES-OXLEY ACT OF 2002**

I,Zhilin Li,the Chief Executive Officer ofChina Pharma Holdings, Inc.,certify that:        1)     I have reviewed thisannualreport on Form 10-KofChina Pharma Holdings, Inc;

2)     Based on my knowledge, this report does not contain any untruestatement of a material fact or omit to state a material factnecessary to make the statements made, in light of the circumstancesunder which such statements were made, not misleading with respect tothe period covered by this report;

3)     Based on my knowledge, the financial statements, and other financialinformation included in this report, fairly present in all materialrespects the financial condition, results of operations and cash flowsof the small business issuer as of, and for, the periods presented inthis report;

4)     The small business issuer's other certifying officer(s) and I areresponsible for establishing and maintaining disclosure controls andprocedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e))and internal control over financial reporting (as defined in ExchangeAct Rules 13a-15(f) and 15d-15(f)) for the small business issuer andhave:        a)     Designed such disclosure controls and procedures, or caused suchdisclosure controls and procedures to be designed under oursupervision, to ensure that material information relating to thesmall business        issuer, including its consolidated subsidiaries,is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;        b)     Designed such internal control over financial reporting, orcaused such internal control over financial reporting to bedesigned under our supervision, to provide reasonable assuranceregarding the        reliability of financial reporting and thepreparation of financial statements for external purposes inaccordance with generally accepted accounting principles;         

c)     Evaluated the effectiveness of the small business issuer'sdisclosure controls and procedures and presented in this reportour conclusions about the effectiveness of the disclosurecontrols and procedures, as of the end of the period covered bythis report based on such evaluation; and

d)     Disclosed in this report any change in the small businessissuer's internal control over financial reporting that occurredduring the small business issuer's most recent fiscal quarterthat has materially affected, or is reasonablylikely to materially affect, the small business issuer's internalcontrol over financial reporting; and

5)     The small business issuer's other certifying officer(s) and I havedisclosed, based on our most recent evaluation of internal controlover financial reporting, to the small business issuer's auditors andthe audit committee of the small business issuer's board of directors(or persons        performing the equivalent functions):                 a) All significant deficiencies and material weaknesses in thedesign or operation of internal control over financial reportingwhich are reasonably likely to adversely affect the small business issuer's ability to record, process, summarize andreport financial information; and                 b) Any fraud, whether or not material, that involves management orother employees who have a significant role in the small businessissuer's internal control over financial reporting.                  

> 
Date:March17, 2009

> 
By:/s/ Zhilin Li

Zhilin Li

Chief Executive Officer